Copyright
©The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Apr 14, 2020; 26(14): 1546-1553
Published online Apr 14, 2020. doi: 10.3748/wjg.v26.i14.1546
Published online Apr 14, 2020. doi: 10.3748/wjg.v26.i14.1546
SARS-COV-2 infection (coronavirus disease 2019) for the gastrointestinal consultant
Kaveh Hajifathalian, Srihari Mahadev, Robert E Schwartz, Shawn Shah, Kartik Sampath, Felice Schnoll-Sussman, Robert S Brown Jr, David Carr-Locke, David E Cohen, Reem Z Sharaiha, Division of Gastroenterology and Hepatology, Weill Cornell Medicine, New York-Presbyterian Hospital, New York, NY 10021, United States
Author contributions: Hajifathalian K, Mahadev S, Schwartz RE, Shah S and Sharaiha RZ performed the review of literature; Hajifathalian K, Sharaiha RZ, Sampath K, Schnoll-Sussman F, Brown Jr RS, Carr-Locke D, and Cohen DE wrote the manuscript; Sharaiha RZ developed the idea for the manuscript.
Conflict-of-interest statement: The authors declare that they have no conflict of interest.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Corresponding author: Reem Z Sharaiha, MD, Associate Professor, Division of Gastroenterology and Hepatology, Weill Cornell Medicine, New York-Presbyterian Hospital, 1283 York Avenue, 9th floor, New York, NY 10021, United States. rzs9001@med.cornell.edu
Received: March 23, 2020
Peer-review started: March 23, 2020
First decision: March 31, 2020
Revised: April 8, 2020
Accepted: April 11, 2020
Article in press: April 11, 2020
Published online: April 14, 2020
Peer-review started: March 23, 2020
First decision: March 31, 2020
Revised: April 8, 2020
Accepted: April 11, 2020
Article in press: April 11, 2020
Published online: April 14, 2020
Core Tip
Core tip: The coronavirus disease 2019 (COVID-19) has become the first pandemic of the 21st century, engaging the health care providers in almost all countries around the world. Similar to previous coronavirus infections such as severe acute respiratory syndrome coronavirus, the COVID-19 is associated with a high prevalence of gastrointestinal (GI) and liver manifestations and abnormalities. Here we present a comprehensive summary of the available evidence on GI involvement of COVID-19 and its implications for the GI consultants.